Jordana Joy, Editor

The company's lead product candidate Duravyu (vorolanib intravitreal insert), f/k/a EYP-1901, is anticipating topline data from several clinical trials in 2026.

The company will prioritize its cash in funding its ongoing Phase 1/2 PRISM clinical trial and Phase 3 4FRONT program.

The webinar will overview new offerings, details about the show’s updated brand and new exhibit hall layout, special events, and announcements regarding this year’s keynote speaker and other main stage sessions.

The new standards touch on alignment, terminology, expectations, and adherence, according to the council.

Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.

Catch up on what happened in optometry during the week of January 6-January 10.

The educational resources is now being used in 64% of the world's countries, with the US, the United Kingdom, Malaysia, India, Australia, and Canada as the most frequent users.

The module provides eye care professionals access to advanced thickness mapping and data insights for evaluating epithelial and stromal structures.

A recent study evaluated both deep neural networks and aggregation functions to determine ways to improve schizophrenia detection.

The 3-arm, multicenter, randomized, double masked, safety and efficacy study successfully met pre-specified visual acuity primary endpoints with statistically significant near vision improvements recorded at all time points over 8 hours.

EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.

Catch up on what happened in optometry during the week of December 30-January 3.

Model simulations conducted in part to assess net monetary benefit found that comprehensive eye examinations every 3 years were more cost effective than less frequent examinations.

From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.

From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.

Catch up on what happened in optometry during the week of December 23-December 27.

One of the new resources are Spanish closed captioning on educational videos to expand their reach to Latin American countries.

Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.

If approved, Glaukos states that Epioxa would be the first FDA-approved, non-invasive corneal cross-linking therapy that does not require removal of the corneal epithelium.

Catch up on what happened in optometry during the week of December 16-December 20.

The American Optometric Association and Association of Armed Forces and Federal Optometric Services have advocated for the legislature’s passage.

Reviewing new AMD treatments and research can help optometrists prepare for what's to come in 2025.

Optometrists reflect on their residency experiences and provide advice to current residents.

EnVision Summit optometry faculty Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.

Mice with reduced levels of ERCC1-XPF in the study presented abnormal optokinetic and electroretinogram responses consistent with photoreceptor dysfunction and visual impairment.

Optometrists weigh in on the importance of building patient loyalty.

Catch up on what happened in optometry during the week of December 9-December 13.

Brush up your geographic atrophy knowledge with our 2024 content highlights.

All 6 biomarkers in the study demonstrated improvement with the treatment of lifitegrast, according to Thimons.

Catch up on what happened in optometry during the week of December 2-December 6.